Pharmacognosy intro
Chrysopogon zizanioides (L.) Roberty (syn. Vetiveria zizanioides), family Poaceae, is a perennial grass whose essential oil is steam-distilled exclusively from the roots. The grass itself is scentless; all aromatic and bioactive compounds reside in the root system, which can reach 3-4 meters deep. Known as vetiver, khus or khus-khus (Hindi), uskur (Arabic), and vettiveru (Tamil), the plant is cultivated commercially in Haiti, Java, Reunion, India, and Brazil. Vetiver oil is one of the most chemically complex essential oils known, with over 300 identified sesquiterpene compounds spanning zizaane, vetivane, eremophilane, and eudesmane carbon skeletons. Two distinct chemotypes exist: the "typical" chemotype (Haiti, Java, Reunion, Brazil) dominated by alpha-vetivone and beta-vetivone (sesquiterpene ketones responsible for the characteristic scent), and the "Khus" chemotype (North India, wild, fertile plants) where these vetivones are absent and khusinol predominates. Khusimol, a sesquiterpene alcohol present across chemotypes, is the characteristic odorant and demonstrates antioxidant activity. Vetiverol contributes anti-inflammatory and warm-woody properties. Zizanoic acid provides anti-inflammatory effects. Khusenic acid has been identified as the major compound with cytotoxic activity against oral cancer cells. The definitive analytical review by Belhassen et al. (2014, Flavour and Fragrance Journal) catalogued 300+ volatile constituents, clarified chemotype distinctions, and documented antifungal, antibacterial, anticancer, anti-inflammatory, and antioxidant activities across the oil's compound classes. Grover et al. (2021) demonstrated cytotoxic activity against oral cancer cell lines with khusenic acid as the primary active agent, alongside significant antioxidant capacity. Lizarraga-Valderrama (2020, Phytotherapy Research) positioned vetiver among essential oils with documented central nervous system effects in a comprehensive review, noting the complex sesquiterpene profile as relevant to neuropharmacological activity. Human clinical trials specifically isolating vetiver's anxiolytic effects remain limited; the calming reputation is supported by the CNS-active sesquiterpene profile and traditional use rather than controlled human efficacy data. The oil holds GRAS status, has very low sensitization risk, and no significant drug interactions are documented at aromatherapy doses.